GC, M., ML, P., MB, B., KD, D., D, K., BR, E., & JA, S. (2026). Early screening for rheumatoid arthritis-associated interstitial lung disease: Statistical nuances challenge the role of disease activity - Authors' reply. The Lancet. Rheumatology, 8(3), e165. https://doi.org/10.1016/S2665-9913(26)00004-4
Chicago Style (17th ed.) CitationGC, McDermott, Paudel ML, Bolster MB, Deane KD, Khanna D, England BR, and Sparks JA. "Early Screening for Rheumatoid Arthritis-associated Interstitial Lung Disease: Statistical Nuances Challenge the Role of Disease Activity - Authors' Reply." The Lancet. Rheumatology 8, no. 3 (2026): e165. https://doi.org/10.1016/S2665-9913(26)00004-4.
MLA (9th ed.) CitationGC, McDermott, et al. "Early Screening for Rheumatoid Arthritis-associated Interstitial Lung Disease: Statistical Nuances Challenge the Role of Disease Activity - Authors' Reply." The Lancet. Rheumatology, vol. 8, no. 3, 2026, p. e165, https://doi.org/10.1016/S2665-9913(26)00004-4.